Tholkappian R, NIT Durgapur Nirmatrelvir is an oral inhibitor of the SARS-CoV-2’s, 3-chymotrypsin–like cysteine protease, while VV116 is a deuterated remdesivir hydro-bromide with potent activity against SARS-CoV-2. Nirmatrelvir-ritonavir was used to treat COVID-19 of low to moderate severity. However, its production could not meet the global supply demands. VV116 is one such oral analog of […]
Ananya Ghosal, MAKAUT(WB) COVID-19 vaccine is still a dream for children under 12. Although children are not at risk of COVID-19 like adults, their reports are still positive. The delta variant and reopening of schools combined and resulted in a keen rise in pediatric COVID-19 cases that is related to the records in the pandemic. […]
Priyanka Saha, Amity University Kolkata Introduction Senolytics are a special class of drugs that eliminate old or senescent cells (SC) in the body. They are developed to prevent or delay age-related diseases in humans. The word senolytics is connected to “Senostatic” which refers to suppressing senescence. Most of the senolytic agents are in the early […]
Laiba Saleem, Aligarh Muslim University Artificial Intelligence (AI) is not any doubt the core way forward for IT, and together with machine learning and data science it holds significant potential in majority fields, and the medicinal industry is not any stranger thereto. From medical/surgical robotics to microchips containing the anamnesis of patients, AI has come […]
Saptaparna Dasgupta, Bennett University The COVID-19 vaccine has been created as an emergency vaccine, based on several strategies, such as mRNA vaccine, inactivated virus vaccine, etc. The other vaccines having cleared the clinical trials have passed on to the mass population vaccination drives, without any reported risk factors, yet. However, Johnson and Johnson’s COVID 19 […]
Avani Dave, Jai Hind College A recent study conducted by Satveer Mahil et al., showcased in the current year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) and published in The Lancet Rheumatology, demonstrates that it is not the response of T-cell but that of the antibody to the first jab of the Pfizer […]
Anjali Kumari, IILM College of Engineering and Technology Longer gap (up to 45 weeks) between the Covid-19 vaccines may increase the immune response. According to a new study from the University of Oxford in the United Kingdom, it has been stated that a gap of up to 45 weeks between the first and second doses […]
Esha Mohite, MGM College of Engineering and Technology What is SCS? Spinal Cord Stimulation (SCS) is a therapy recommended for patients with chronic pain in the leg, back, and chest. A spinal cord stimulator is an electronic device that is inserted under the skin surgically. It is made up of many parts, but its three […]
Anuska Sen, Team BioXone The International Clinical Trials Day is celebrated on the 20th of May each year to commemorate the enormous contributions of clinical trials and their participants to the various fields of science. The purpose of celebrating this day is to let people know about the importance of clinical trials and spread the […]
Surupa Chakraborty, Amity University Kolkata A new gene therapy clinical trial for treating Angelman syndrome has been put to hold after two candidates temporarily lost their ability to walk. GTX102, the drug used in the clinical trial was developed by a California-based biopharmaceutical company Ultragenyx, in collaboration with GeneTx, a Florida-based biotech startup. The trial […]
